These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38395466)
1. Diffuse Pneumonitis after Lutetium-177-PSMA-617 Treatment in a Patient with Metastatic Castration-Resistant Prostate Cancer. Wang JS; Wong T; Wu KA; Mullikin TC; Armstrong A BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38395466 [TBL] [Abstract][Full Text] [Related]
2. [ Hofman MS; Violet J; Hicks RJ; Ferdinandus J; Thang SP; Akhurst T; Iravani A; Kong G; Ravi Kumar A; Murphy DG; Eu P; Jackson P; Scalzo M; Williams SG; Sandhu S Lancet Oncol; 2018 Jun; 19(6):825-833. PubMed ID: 29752180 [TBL] [Abstract][Full Text] [Related]
3. Lutetium Lu 177 vipivotide tetraxetan for metastatic castration-resistant prostate cancer. Shah H; Ravi P; Sonpavde G; Jacene H Expert Rev Anticancer Ther; 2022 Nov; 22(11):1163-1175. PubMed ID: 36305305 [TBL] [Abstract][Full Text] [Related]
4. Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. Sartor O; de Bono J; Chi KN; Fizazi K; Herrmann K; Rahbar K; Tagawa ST; Nordquist LT; Vaishampayan N; El-Haddad G; Park CH; Beer TM; Armour A; Pérez-Contreras WJ; DeSilvio M; Kpamegan E; Gericke G; Messmann RA; Morris MJ; Krause BJ; N Engl J Med; 2021 Sep; 385(12):1091-1103. PubMed ID: 34161051 [TBL] [Abstract][Full Text] [Related]
15. Zang J; Liu Q; Sui H; Wang R; Jacobson O; Fan X; Zhu Z; Chen X J Nucl Med; 2020 Dec; 61(12):1772-1778. PubMed ID: 32358086 [TBL] [Abstract][Full Text] [Related]
16. Influence of short-term dexamethasone on the efficacy of Derlin T; Sommerlath Sohns JM; Schmuck S; Henkenberens C; von Klot CAJ; Ross TL; Bengel FM Prostate; 2020 May; 80(8):619-631. PubMed ID: 32187729 [TBL] [Abstract][Full Text] [Related]
17. Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with Heck MM; Tauber R; Schwaiger S; Retz M; D'Alessandria C; Maurer T; Gafita A; Wester HJ; Gschwend JE; Weber WA; Schwaiger M; Knorr K; Eiber M Eur Urol; 2019 Jun; 75(6):920-926. PubMed ID: 30473431 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy and safety results of 177Lu-PSMA therapy in metastatic castration-resistant prostate cancer patients: first experience of a developing South Asian Country. Parveen A; Fatima A; Fatima I; Khan IU; Shahid A Nucl Med Commun; 2023 Oct; 44(10):876-887. PubMed ID: 37440195 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of Violet J; Sandhu S; Iravani A; Ferdinandus J; Thang SP; Kong G; Kumar AR; Akhurst T; Pattison DA; Beaulieu A; Mooi J; Tran B; Guo C; Kalff V; Murphy DG; Jackson P; Eu P; Scalzo M; Williams S; Hicks RJ; Hofman MS J Nucl Med; 2020 Jun; 61(6):857-865. PubMed ID: 31732676 [No Abstract] [Full Text] [Related]
20. Therapeutic Multidose Preparation of a Ready-to-Use Chakraborty A; Mitra A; Tawate M; Sahoo S; Lad S; Rakshit S; Gaikwad S; Basu S; Shimpi H; Banerjee S Cancer Biother Radiopharm; 2021 Oct; 36(8):682-692. PubMed ID: 34402687 [No Abstract] [Full Text] [Related] [Next] [New Search]